These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28258520)

  • 1. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study.
    Brahimaj A; Ligthart S; Ghanbari M; Ikram MA; Hofman A; Franco OH; Kavousi M; Dehghan A
    Eur J Epidemiol; 2017 Mar; 32(3):217-226. PubMed ID: 28258520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant versus animal based diets and insulin resistance, prediabetes and type 2 diabetes: the Rotterdam Study.
    Chen Z; Zuurmond MG; van der Schaft N; Nano J; Wijnhoven HAH; Ikram MA; Franco OH; Voortman T
    Eur J Epidemiol; 2018 Sep; 33(9):883-893. PubMed ID: 29948369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of early adulthood pre-diabetes/type 2 diabetes, among Iranian adolescents: the Tehran Lipid and Glucose Study.
    Mirbolouk M; Derakhshan A; Charkhchi P; Guity K; Azizi F; Hadaegh F
    Pediatr Diabetes; 2016 Dec; 17(8):608-616. PubMed ID: 26764014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EN-RAGE: a novel inflammatory marker for incident coronary heart disease.
    Ligthart S; Sedaghat S; Ikram MA; Hofman A; Franco OH; Dehghan A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2695-9. PubMed ID: 25341801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein partially mediates the inverse association between coffee consumption and risk of type 2 diabetes: The UK Biobank and the Rotterdam study cohorts.
    Ochoa-Rosales C; van der Schaft N; Braun KVE; Ho FK; Petermann-Rocha F; Ahmadizar F; Kavousi M; Pell JP; Ikram MA; Celis-Morales CA; Voortman T
    Clin Nutr; 2023 May; 42(5):661-669. PubMed ID: 36940600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes.
    Croyal M; Wargny M; Chemello K; Chevalier C; Blanchard V; Bigot-Corbel E; Lambert G; Le May C; Hadjadj S; Cariou B
    Cardiovasc Diabetol; 2022 Feb; 21(1):21. PubMed ID: 35130909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
    Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
    Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes.
    Grossmann V; Schmitt VH; Zeller T; Panova-Noeva M; Schulz A; Laubert-Reh D; Juenger C; Schnabel RB; Abt TG; Laskowski R; Wiltink J; Schulz E; Blankenberg S; Lackner KJ; Münzel T; Wild PS
    Diabetes Care; 2015 Jul; 38(7):1356-64. PubMed ID: 25877811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E;
    PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of liver enzyme levels as predictive markers of glucose metabolism disorders in a Tunisian population.
    Bouhajja H; Abdelhedi R; Amouri A; Hadj Kacem F; Marrakchi R; Safi W; Mrabet H; Chtourou L; Charfi N; Fourati M; Bensassi S; Jamoussi K; Abid M; Ayadi H; Mnif-Feki M; Bougacha-Elleuch N
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1171-1180. PubMed ID: 29527933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum zinc and risk of type 2 diabetes incidence in men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
    Yary T; Virtanen JK; Ruusunen A; Tuomainen TP; Voutilainen S
    J Trace Elem Med Biol; 2016 Jan; 33():120-4. PubMed ID: 26653753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study.
    Pan A; Wang Y; Yuan JM; Koh WP
    BMC Endocr Disord; 2017 Feb; 17(1):8. PubMed ID: 28178951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.
    Ligthart S; van Herpt TT; Leening MJ; Kavousi M; Hofman A; Stricker BH; van Hoek M; Sijbrands EJ; Franco OH; Dehghan A
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):44-51. PubMed ID: 26575606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: The Rotterdam Study.
    van der Schaft N; Brahimaj A; Wen KX; Franco OH; Dehghan A
    PLoS One; 2017; 12(6):e0179482. PubMed ID: 28632742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study.
    Olubamwo OO; Virtanen JK; Pihlajamaki J; Tuomainen TP
    BMJ Open; 2019 Jul; 9(7):e026949. PubMed ID: 31278098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of type 2 diabetes and an inflammatory marker with incident bone fracture among a Japanese cohort.
    Mitama Y; Fujiwara S; Yoneda M; Kira S; Kohno N
    J Diabetes Investig; 2017 Sep; 8(5):709-715. PubMed ID: 28122172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of incident prediabetes and type 2 diabetes in a 7-year cohort in a developing country: The Isfahan Cohort Study.
    Sadeghi M; Talaei M; Parvaresh Rizi E; Dianatkhah M; Oveisgharan S; Sarrafzadegan N
    J Diabetes; 2015 Sep; 7(5):633-41. PubMed ID: 25350916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
    Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes.
    Oxenkrug GF
    Mol Neurobiol; 2015 Oct; 52(2):805-10. PubMed ID: 26055228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study.
    Huth C; von Toerne C; Schederecker F; de Las Heras Gala T; Herder C; Kronenberg F; Meisinger C; Rathmann W; Koenig W; Waldenberger M; Roden M; Peters A; Hauck SM; Thorand B
    Eur J Epidemiol; 2019 Apr; 34(4):409-422. PubMed ID: 30599058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.